HIV Protease Inhibitor Pharmacokinetics

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: {| class="wikitable" border="1" width="52%" style="text-align:center" |- ! colspan="12" align="center"| HIV Protease Inhibitor Pharmacokinetics |- ! Parameter ! Ritonavir ! [[Tipr...)
Current revision (09:19, 10 December 2010) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
{| class="wikitable" border="1" width="52%" style="text-align:center"
+
{| class="wikitable" border="1" width="100%" style="text-align:center"
|-
|-
! colspan="12" align="center"| HIV Protease Inhibitor [[Pharmacokinetics]]
! colspan="12" align="center"| HIV Protease Inhibitor [[Pharmacokinetics]]
Line 123: Line 123:
! Hepatic (CYP3A4)
! Hepatic (CYP3A4)
|}
|}
-
For References, See: [[Treatments:HIV Protease Inhibitor Pharmacokinetics References|References]]
+
For Pharmacokinetic Data References, See: [[Treatments:HIV Protease Inhibitor Pharmacokinetics References|References]]

Current revision

HIV Protease Inhibitor Pharmacokinetics
Parameter Ritonavir Tipranavir Indinavir Saquinavir Amprenavir Fosamprenavir Lopinavir Darunavir Atazanavir Nelfinavir
Tmax (hr) 4.4 ~3 1.5 3.7 .98 1.5-4 2 .5 2-4 3.1
Cmax (ng/ml) 13120 14600 8100 2297 4901 4820 11.9 2730 ~4393 4701
Bioavailability (%) -- -- 65 4 -- -- -- -- 68 20-80
Protein Binding (%) 99 >99 61 98 90 90 99 95 86 98
T1/2 (hr) 4.8 4.2 1.2 4.5 5.5 7.7 6.1 29.4 5.3 3.3
AUC (ng/ml/hr) 128100 46500 20900 13467 11999 35000 117600 4746 ~26045 31906
Clearance (L/h) ~8.4 32.4 49.5 36.7 56.8 84.4 1.7 32.8 13.6 37.3
Dosage (mg) 600 600 800 1000 600 1400 280 400 400 1250
Metabolism Hepatic (CYP3A4 & CYP2C19) Hepatic (CYP3A4) Hepatic (CYP3A4) Hepatic (CYP3A4 & CYP3A5) Hepatic (CYP3A4) Hepatic (CYP3A4) Hepatic (CYP3A4) Hepatic (CYP3A4) Hepatic (CYP3A4) Hepatic (CYP3A4)

For Pharmacokinetic Data References, See: References

Proteopedia Page Contributors and Editors (what is this?)

David Canner

Personal tools